Lpl Financial LLC Immatics N.V. Transaction History

Lpl Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.58 - $15.46 $151,037 - $201,644	-13,043 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$10.24 - $14.6 $1,024 - $1,460	100 Added 0.77%	13,043 $146,000
Q4 2020 Feb 12, 2021	BUY	$9.67 - $12.05 $20,016 - $24,943	2,070 Added 19.04%	12,943 $140,000
Q3 2020 Nov 09, 2020	BUY	$8.73 - $15.15 $94,921 - $164,725	10,873 New	10,873 $115,000

68.8M

507K

170K

Ticker IMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,227,000
Market Cap $886M
Description
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.